ANAnastasia Nikiforova

Anastasia Nikiforova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasia Nikiforova has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Use of faricimab in neovascular age-related macular degeneration and diabetic macular edema in Russia. Results of the FARWATER retrospective study

    by N.V. Neroeva, A.ZH. Fursova, R.R. Faizrakhmanov, A.A. Plyukhova, E.V. Bobykin, M.V. Gordeeva, E.V. Karlova, E.D. Bosov, A.A. Nikiforova

    Despite the positive outcomes of anti-VEGF therapy, neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) remain major medical and social challenges, and optimization of their treatment is an urgent need. Purpose. This study evaluated the effectiveness of Vabysmo (faricimab) in the treatment of patients with nAMD and DME in real-world clinical practice in Russia. Material and methods. A multicenter retrospective analysis was conducted based on the medical records of 328 patients (370 eyes) with nAMD and 87 patients (112 eyes) with DME (both treatment-naïve and previously treated with anti-VEGF agents) who received faricimab from July 2023 to February 2025. The following primary effectiveness indicators were assessed: changes in visual acuity (VA) and central retinal thickness (CRT) after the first four faricimab injections. Secondary outcome indicators included changes in VA, CRT, and selected disease biomarkers at 6, 12, and 18 months of treatment, as well as injection intervals during the maintenance phase. Results. After the first four consecutive faricimab injections, VA improved by 8.1 ETDRS letters (p<0.05) in the nAMD group and by 12.8 ETDRS letters (p<0.05) in the DME group. CRT decreased by 103.3 μm (p<0.05) and 177.4 μm (p<0.05), respectively. These improvements remained stable during further follow-up (8.78±4.51 months in the nAMD group and 10.48±5.24 months in the DME group, up to a maximum of 19 months in both groups). The proportion of patients who achieved injection intervals of ≥12 weeks was 27.9% in the nAMD group and 38.5% in the DME group. Conclusion. Faricimab demonstrated high clinical effectiveness in real-world settings in patients with nAMD and DME, with the potential to reduce the treatment burden for patients and the healthcare system.

  • Open Access

    Automated diagnostics of epiretinal membrane on OCT images using deep learning algorithms

    by A. D. Pershin, D. D. Khardin, A. A. Nikiforova, A. A. Dvornikova, A. D. Stepichev, M. K. Kulyabin, V. I. Borisov

    Purpose: to develop and evaluate the effectiveness of a neural network model for automatic segmentation of epiretinal membrane (ERM) in optical coherence tomography (OCT) images. Materials and methods. The study includes 322 labeled macular OCT scans with signs of ERM: 167 from the private dataset of the “Professorskaya Plus” clinic and 155 from the public OCTDL dataset. Five architectures were selected for comparison: U-Net, Attention U-Net, TransUNet, LOCTSeg, and Tiny-UNet. Initial annotations were generated using a baseline U-Net model and underwent expert clinical validation. Segmentation performance was assessed using Dice coefficient and Intersection over Union (IoU). Annotation quality was ensured by three experienced ophthalmologists with over 10 years of clinical practice. Results. All models demonstrated comparable Dice and IoU scores, with no statistically significant differences. Tiny-UNet showed the best balance of accuracy and computational efficiency: 570K parameters, 5× faster training per epoch than U-Net, and total training time of only 20 min. Segmentation accuracy reached Dice = 86.1 %, IoU = 78.6 %. Conclusion. Tiny-UNet appears to be the optimal architecture for ERM segmentation tasks, offering high accuracy with minimal computational requirements. Its efficiency makes it suitable for clinical deployment, including in mobile and cloud-based telemedicine platforms.

  • Open Access

    Segment Anything in Optical Coherence Tomography: SAM 2 for Volumetric Segmentation of Retinal Biomarkers

    by Mikhail Kulyabin, Aleksei Zhdanov, Andrey Pershin, Gleb Sokolov, Anastasia Nikiforova, Mikhail Ronkin, Vasilii Borisov, Andreas Maier

    Optical coherence tomography (OCT) is a non-invasive imaging technique widely used in ophthalmology for visualizing retinal layers, aiding in the early detection and monitoring of retinal diseases. OCT is useful for detecting diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), which affect millions of people globally. Over the past decade, the area of application of artificial intelligence (AI), particularly deep learning (DL), has significantly increased. The number of medical applications is also rising, with solutions from other domains being increasingly applied to OCT. The segmentation of biomarkers is an essential problem that can enhance the quality of retinal disease diagnostics. For 3D OCT scans, AI is beneficial since manual segmentation is very labor-intensive. In this paper, we employ the new SAM 2 and MedSAM 2 for the segmentation of OCT volumes for two open-source datasets, comparing their performance with the traditional U-Net. The model achieved an overall Dice score of 0.913 and 0.902 for macular holes (MH) and intraretinal cysts (IRC) on OIMHS and 0.888 and 0.909 for intraretinal fluid (IRF) and pigment epithelial detachment (PED) on the AROI dataset, respectively.


  • Open Access

    Segment Anything in OCT: SAM 2 for Volumetric Segmentation of Retinal Biomarkers

    by Mikhail Kulyabin, Aleksei Zhdanov, Andrey Pershin, Gleb Sokolov, Anastasia Nikiforova, Mikhail Ronkin, Vasilii I Borisov, Andreas Maier

    Optical coherence tomography (OCT) is a non-invasive imaging technique widely used in ophthalmology for visualizing retinal layers, aiding in early detection and monitoring of retinal diseases. OCT is useful for detecting diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), which affect millions of people globally. Over the past decade, the area of application of Artificial Intelligence (AI), particularly Deep Learning (DL), has significantly increased. The number of medical applications is also rising, with solutions from other domains being increasingly applied to OCT. The segmentation of biomarkers is an essential problem that can enhance the quality of retinal disease diagnostics. For 3D OCT scans, AI is beneficial since manual segmentation is very labor-intensive. In this paper, we employ the new SAM 2 and MedSAM 2 for the segmentation of OCT volumes for two open-source datasets, comparing their performance with the traditional U-Net. The model achieved an overall Dice score of 0.913 and 0.902 for macular holes (MH) and intraretinal cysts (IRC) on OIMHS and 0.888 and 0.909 for intraretinal fluid (IRF) and pigment epithelial detachment (PED) on the AROI dataset, respectively.


  • Top Cited Papers
    Open Access

    OCTDL: Optical Coherence Tomography Dataset for Image-Based Deep Learning Methods

    by Mikhail Kulyabin, Aleksei Zhdanov, Anastasia Nikiforova, Andrey Stepichev, Anna Kuznetsova, Mikhail Ronkin, Vasilii Borisov, Alexander Bogachev, Sergey Korotkich, Paul A. Constable, et al.

    Optical coherence tomography (OCT) is a non-invasive imaging technique with extensive clinical applications in ophthalmology. OCT enables the visualization of the retinal layers, playing a vital role in the early detection and monitoring of retinal diseases. OCT uses the principle of light wave interference to create detailed images of the retinal microstructures, making it a valuable tool for diagnosing ocular conditions. This work presents an open-access OCT dataset (OCTDL) comprising over 2000 OCT images labeled according to disease group and retinal pathology. The dataset consists of OCT records of patients with Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Epiretinal Membrane (ERM), Retinal Artery Occlusion (RAO), Retinal Vein Occlusion (RVO), and Vitreomacular Interface Disease (VID). The images were acquired with an Optovue Avanti RTVue XR using raster scanning protocols with dynamic scan length and image resolution. Each retinal b-scan was acquired by centering on the fovea and interpreted and cataloged by an experienced retinal specialist. In this work, we applied Deep Learning classification techniques to this new open-access dataset.